Borderline Resectable Pancreatic Cancer: What Have We Learned and Where Do We Go From Here?

By Katz Matthew  

Annals of Surgical Oncology, Vol. 18, Iss. 3, 2011-03 ,pp. : 608-610

Springer Publishing Company

Access to resources Recommend Favorite

Dissemination research in cancer control: where are we and where should we go?

By Bowen Deborah  

Cancer Causes and Control, Vol. 20, Iss. 4, 2009-05 ,pp. : 473-485

Springer Publishing Company

Access to resources Recommend Favorite

Antibiofilm agents and implant-related infections in orthopaedics: where are we?

By Roman? Carlo L  

Journal of Chemotherapy, Vol. 25, Iss. 2, 2013-04 ,pp. : 67-80

Maney Publishing

Access to resources Recommend Favorite

How can we improve the quality of reporting family history in colorectal cancer care? (And why does it matter?)

By Wilson Brenda J  

Colorectal Cancer, Vol. 2, Iss. 2, 2013-04 ,pp. : 99-102

Future Medicine

Access to resources Recommend Favorite

Clinical complete response in locally advanced rectal cancer: can we offer a wait-and-see policy?

By Hernndez-Garca I.   Videz A.   Surez J.   Arias De la Vega F.   Vera R.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 853-853

Oxford University Press

Access to resources Recommend Favorite